OtherGastrointestinal, Hepatic, Pulmonary, and Renal
The HMG CoA-Reductase Inhibitor Pravastatin Reduces Disease Activity and Inflammation in Dextran-Sulfate Induced Colitis
Makoto Sasaki, Sulaiman Bharwani, Paul Jordan, Takashi Joh, Kenneth Manas, April Warren, Hirohisa Harada, Patsy Carter, John W. Elrod, Michael Wolcott, Matthew B. Grisham and J. Steven Alexander
Journal of Pharmacology and Experimental Therapeutics January 21, 2003, DOI: https://doi.org/10.1124/jpet.102.044099
Makoto Sasaki
Sulaiman Bharwani
Paul Jordan
Takashi Joh
Kenneth Manas
April Warren
Hirohisa Harada
Patsy Carter
John W. Elrod
Michael Wolcott
Matthew B. Grisham
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherGastrointestinal, Hepatic, Pulmonary, and Renal
The HMG CoA-Reductase Inhibitor Pravastatin Reduces Disease Activity and Inflammation in Dextran-Sulfate Induced Colitis
Makoto Sasaki, Sulaiman Bharwani, Paul Jordan, Takashi Joh, Kenneth Manas, April Warren, Hirohisa Harada, Patsy Carter, John W. Elrod, Michael Wolcott, Matthew B. Grisham and J. Steven Alexander
Journal of Pharmacology and Experimental Therapeutics January 21, 2003, DOI: https://doi.org/10.1124/jpet.102.044099
OtherGastrointestinal, Hepatic, Pulmonary, and Renal
The HMG CoA-Reductase Inhibitor Pravastatin Reduces Disease Activity and Inflammation in Dextran-Sulfate Induced Colitis
Makoto Sasaki, Sulaiman Bharwani, Paul Jordan, Takashi Joh, Kenneth Manas, April Warren, Hirohisa Harada, Patsy Carter, John W. Elrod, Michael Wolcott, Matthew B. Grisham and J. Steven Alexander
Journal of Pharmacology and Experimental Therapeutics January 21, 2003, DOI: https://doi.org/10.1124/jpet.102.044099
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement